BMS 6063 500
Generic Name: metformin
Pill imprint BMS 6063 500 has been identified as Glucophage XR 500 mg.
Glucophage XR is used in the treatment of diabetes, type 2; insulin resistance syndrome and belongs to the drug class non-sulfonylureas. There is no proven risk in humans during pregnancy.
Glucophage XR 500 mg is not subject to the Controlled Substances Act.
See also related documents.
Glucophage XR Images
- Generic Name:
- metformin
- Imprint:
-
BMS 6063
500 - Strength:
- 500 mg
- Color:
- White
- Size:
- 19.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Inactive Ingredients:
- carboxymethylcellulose sodium
hypromellose
microcrystalline cellulose
magnesium stearate
- Drug Class:
- Non-sulfonylureas
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Bristol-Myers Squibb
- National Drug Code (NDC):
- 00087-6063
| NDC Code | Manufacturer / Repackager |
|---|---|
| 54868-4569 | Physicians Total Care Inc (repackager) |
| 66336-0292 | Dispensing Solutions Inc. (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Glucophage XR resources
- Glucophage XR Extended-Release Tablets (Wolters Kluwer)
- Glucophage XR (Cerner Multum)
- Glucophage XR (Micromedex) - Includes Dosage Information
- Glucophage XR (FDA)
Search Again
